Local control of the primary tumour in metastatic neuroblastoma

European Journal of Cancer

Volumn 45, Issue 10, 2009, Pages 1728-1732

  Sultan, Iyad ^a   Ghandour, Khalil ^a   Al Jumaily, Usama ^a   Hashem, Sameh ^a   Rodriguez Galindo, Carlos ^b  

^a King Hussein Cancer Centre   (Jordan)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Complete resection; High risk neuroblastoma; Radiotherapy; SEER; Tumour size

Indexed keywords

ADRENAL TUMOR; ADULT; ARTICLE; CANCER CONTROL; CANCER SURGERY; CANCER SURVIVAL; CHILD; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; METASTASIS; NEUROBLASTOMA; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; SCHOOL CHILD;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; NEUROBLASTOMA; REGISTRIES; RETROPERITONEAL NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 66949136757     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.021     Document Type: Article

References (20)

1. Goodman MT, Gurney JG, Smith MA, Olshan AF. Sympathetic nervous system tumors. In: Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, MD: NIH Pub. No. 99-4649; 1999. p. 65-72.
2. Mora J., Gerald W.L., Qin J., and Cheung N.K. Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma. Cancer 94 10 (2002) 2756-2765
3. Reynolds C.P. [p]Detection and treatment of minimal residual disease in high-risk neuroblastoma. Pediatr Transplant 8 Suppl 5 (2004) 56-66
4. Matthay K.K., Villablanca J.G., Seeger R.C., Stram D.O., Harris R.E., Ramsay N.K., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. New Engl J Med 341 16 (1999) 1165-1173
5. Kletzel M., Katzenstein H.M., Haut P.R., et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 20 9 (2002) 2284-2292
6. Haas-Kogan D.A., Swift P.S., Selch M., et al. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys 56 1 (2003) 28-39
7. Surveillance, Epidemiology and End Results (SEER) Program . SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2007 Sub (1973-2005 varying) - Linked To County Attributes - Total US, 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission.
8. Schmidt M.L., Lal A., Seeger R.C., Maris J.M., Shimada H., O'Leary M., et al. [p]Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. J Clin Oncol 23 27 (2005) 6474-6480
9. Kushner B.H., and Cheung N.K. Neuroblastoma - from genetic profiles to clinical challenge. New Engl J Med 353 21 (2005) 2215-2217
10. Castel V., Tovar J.A., Costa E., et al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg 37 11 (2002) 1574-1578
11. von Allmen D., Grupp S., Diller L., et al. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 40 6 (2005) 936-941 discussion 941
12. Wolden S.L., Gollamudi S.V., Kushner B.H., et al. Local control with multimodality therapy for stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 46 4 (2000) 969-974
13. Koh C.C., Sheu J.C., Liang D.C., Chen S.H., and Liu H.C. Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma. Pediatr Surg Int 21 2 (2005) 69-72
14. Adkins E.S., Sawin R., Gerbing R.B., London W.B., Matthay K.K., and Haase G.M. Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study. J Pediatr Surg 39 6 (2004) 931-936
15. La Quaglia M.P., Kushner B.H., Su W., et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 39 3 (2004) 412-417 discussion 412-7
16. von Schweinitz D., Hero B., and Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 12 6 (2002) 402-409
17. Shamberger R.C., Smith E.I., Joshi V.V., et al. The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg 33 2 (1998) 161-164
18. Cheung N.K., and Kushner B.H. Risks outweighed benefits from local radiation for non-stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 54 5 (2002) 1575 author reply 1575
19. Kushner B.H., Wolden S., LaQuaglia M.P., et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 19 11 (2001) 2821-2828
20. Simon T., Hero B., Bongartz R., Schmidt M., Muller R.P., and Berthold F. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children >1 year with residual local disease. Strahlenther Onkol 182 7 (2006) 389-394